Mark Toby Joins 4Pines Fund Services LLC
Executive to support 4Pines' strategic growth and focused execution
"4Pines Fund Services is dedicated to providing premium service, aided by extensive private capital experience, industry leading technology solutions, and a collaborative partnership approach that separates us from other fund administrators," said Toby. "The team here has designed our technology platforms and high-touch operating model to address the needs of clients by looking at the fund administration industry first through the client's lens and second as a service provider. I am excited to be a part of this group and the mission we are on."
Mark brings more than 25 years of financial industry experience dedicated exclusively to alternative investments. He served as a Principal at Gen II Fund Services and as Managing Director at Ophedge Investment Services, a
"Mark's addition is further confirmation that we offer the best talent for client-focused strategic services," said
ABOUT 4PINES FUND SERVICES
4Pines is a private capital fund administrator that provides front, middle and back-office solutions which cover the spectrum of a private capital manager's needs. Created and delivered by a leadership team of former industry CFOs and accomplished technology executives, our services are centered around a sophisticated software platform and unparalleled customer service. We pride ourselves on building trusted client relationships on which private equity managers can rely.
For more information visit 4PinesFS.com.
Contact:
View original content:https://www.prnewswire.com/news-releases/mark-toby-joins-4pines-fund-services-llc-302136386.html
SOURCE 4Pines Fund Services
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sunshine Silver Mining & Refining Announces Pricing of Initial Public Offering
- GIGABYTE Showcases Industry-leading CQDIMM Performance and Ecosystem Expansion at COMPUTEX 2026
- 2026 ASCO LBA | Juncell Therapeutics' GC101 TIL Therapy Achieves Primary Endpoint in the Pivotal Phase II Trial for PD-1 Antibody Failed Advanced Melanoma
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Moore Capital ManagementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share